A. Arnold

发表

Human NK cells are alerted to induction of p53 in cancer cells by upregulation of the NKG2D ligands ULBP1 and ULBP2.

Angel Porgador, Nathalie Fiegler, Sonja Textor, 2011, Cancer research.

A tumor vaccine containing anti‐CD3 and anti‐CD28 bispecific antibodies triggers strong and durable antitumor activity in human lymphocytes

A. Arnold, P. Fournier, V. Schirrmacher, 2006, International journal of cancer.

Newcastle disease virus induces pro-inflammatory conditions and type I interferon for counter-acting Treg activity.

A. Arnold, P. Fournier, H. Wilden, 2011, International journal of oncology.

T-cell triggering by CD3- and CD28-binding molecules linked to a human virus-modified tumor cell vaccine.

A. Arnold, P. Fournier, V. Schirrmacher, 2005, Vaccine.

The proto-oncogene Myc drives expression of the NK cell-activating NKp30 ligand B7-H6 in tumor cells

F. Westermann, Sonja Textor, Nathalie Fiegler, 2016, Oncoimmunology.

Targeting anti-tumor DNA vaccines to dendritic cells via a short CD11c promoter sequence.

A. Arnold, P. Fournier, V. Schirrmacher, 2009, Vaccine.

Microenvironment and Immunology Metalloprotease-Mediated Tumor Cell Shedding of B 7-H 6 , the Ligand of the Natural Killer Cell – Activating Receptor NKp 30

P. Altevogt, S. Rose-John, Sonja Textor, 2014 .

CD16A Activation of NK Cells Promotes NK Cell Proliferation and Memory-Like Cytotoxicity against Cancer Cells

J. Koch, A. Arnold, A. Cerwenka, 2018, Cancer Immunology Research.

Single-Cell RNA Sequencing of Tumor-Infiltrating NK Cells Reveals that Inhibition of Transcription Factor HIF-1α Unleashes NK Cell Activity.

T. Höfer, A. Arnold, A. Cerwenka, 2020, Immunity.

Metalloprotease-mediated tumor cell shedding of B7-H6, the ligand of the natural killer cell-activating receptor NKp30.

P. Altevogt, S. Rose-John, Sonja Textor, 2014, Cancer research.

MultiEditR: The first tool for the detection and quantification of RNA editing from Sanger sequencing demonstrates comparable fidelity to RNA-seq

Riccardo Pecori, Marco Binder, Beau R. Webber, 2021, Molecular therapy. Nucleic acids.

Newcastle disease virus induces pro-inflammatory conditions and type I interferon for counteracting Treg activity

A. Arnold, P. Fournier, H. Wilden, 2011 .

Recombinant Newcastle disease virus (NDV) with inserted gene coding for GM-CSF as a new vector for cancer immunogene therapy

A. Arnold, P. Fournier, B. Peeters, 2007, Gene Therapy.

Tumor selective replication of Newcastle disease virus: Association with defects of tumor cells in antiviral defence

A. Arnold, P. Fournier, B. Peeters, 2006, International journal of cancer.

Activation of Natural Killer Cells by Newcastle Disease Virus Hemagglutinin-Neuraminidase

A. Arnold, A. Cerwenka, M. Jarahian, 2009, Journal of Virology.

Downregulation of the activating NKp30 ligand B7-H6 by HDAC inhibitors impairs tumor cell recognition by NK cells.

Sonja Textor, Nathalie Fiegler, A. Arnold, 2013, Blood.

Activation of human T cells by a tumor vaccine infected with recombinant Newcastle disease virus producing IL-2.

A. Arnold, P. Fournier, B. Peeters, 2008, International journal of oncology.

MultiEditR: An easy validation method for detecting and quantifying RNA editing from Sanger sequencing

Marco Binder, Branden S. Moriarity, Mitchell G. Kluesner, 2019, bioRxiv.

Human B lymphoblastoid cell lines provide an interleukin 1-like signal for mitogen-treated T lymphocytes via direct cell contact.

M. Suthanthiran, A. Arnold, S. Lipkowitz, 1985, Journal of immunology.

ADAR1-mediated RNA editing promotes B cell lymphomagenesis

B. Sander, M. Binder, F. Papavasiliou, 2023, iScience.

ADAR RNA editing on antisense RNAs results in apparent U-to-C base changes on overlapping sense transcripts

M. Binder, F. Papavasiliou, E. Picardi, 2023, Frontiers in Cell and Developmental Biology.

RNA-Editing-Initiated MAVS Signaling is a Key Epitranscriptomic Alteration in Human B Cell Lymphoma

B. Sander, R. Pecori, M. Binder, 2021, Social Science Research Network.

Scientific category: IMMUNOBIOLOGY Corresponding Author:

Kai, Gerhard Moldenhauer, Nathalie Fiegler, 2017 .

inhibitors impairs tumor cell recognition by NK cells Downregulation of the activating NKp30 ligand B7-H6 by HDAC

Sonja Textor, Nathalie Fiegler, A. Arnold, 2014 .

Supporting Online Material Materials and Methods Som Text Figs. S1 to S9 References the Asynchronous State in Cortical Circuits

P. Dayan, N. Parga, J. Macke, 2022 .

Metalloprotease-mediated tumor cell shedding of B7-H6, the ligand of the natural killer cell-activating receptor NKp30.

P. Altevogt, S. Rose-John, Sonja Textor, 2014, Cancer research.

Supporting Online Material Materials and Methods Som Text Figs. S1 to S9 References the Asynchronous State in Cortical Circuits

P. Dayan, N. Parga, J. Macke, 2022 .